Finkelstein Thompson LLP Announces Investigation of Nationwide Health Properties, Inc.
WASHINGTON--([ BUSINESS WIRE ])--Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Nationwide Health Properties, Inc. (aNHPa or the aCompanya) (NYSE: NHP) concerning the definitive merger agreement under which NHP would be acquired by Ventas, Inc. (NYSE: VTR) (aVentasa or the aCompanya), and NHP shareholders will receive a fixed exchange ratio of 0.7866 Ventas shares for each share of NHP common stock they own. Based on the closing stock price for Ventas on February 25, 2011, this consideration would be equivalent to $44.99 of Ventas stock for each NHP share. Upon closing of the transaction, Ventas shareholders are expected to own approximately 65% and NHP shareholders are expected to own approximately 35% of the combined company. The transaction is valued at approximately $7.4 billion.
The investigation is focused on the potential unfairness of the consideration to NHP shareholders, the process by which the Board of Directors considered the transaction, and potential conflicts of interests among NHP Board members. According to Yahoo! Finance, at least one analyst has set a target price of $45.00 for NHP stock. Additionally, Ventasa™ board of directors will be expanded to include three directors from NHP, including Douglas M. Pasquale, NHPa™s Chairman, President, and Chief Executive Officer.
If you are interested in discussing your rights as a NHP shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at [ contact@finkelsteinthompson.com ].
Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-lead counsel in dozens of shareholder class actions. Indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers.
To learn more about Finkelstein Thompson LLP, please visit our web site at [ www.finkelsteinthompson.com ]. Attorney advertising. Prior results do not guarantee similar outcomes.